An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma
- PMID: 67099
- DOI: 10.1159/000149972
An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma
Abstract
An indirect immunofluorescence (IF) test on fixed cells with Evans' blue counterstain is described for all four human herpesviruses, i.e., herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2), varicella-zoster virus (VZV), cytomegalovirus (CMV) and Epstein-Barr virus (EBV). Comparison with immunodiffusion (ID) for HSV-2 and with ID and complement fixation (CF) for VZV and CMV demonstrated the specificity and high sensitivity of the IF test. Also introduced is a modification of the anti-complement immunofluorescence (ACIF) test for EBV-determined nuclear antigen (EBNA), permitting simultaneous titration of antibodies to this nuclear antigen and of the anti-nuclear factor (ANF). Seroepidemiological studies of these viruses in patients with Hodgkin's disease (HD) in the Netherlands revealed the following pattern: (1) in nodular sclerosing (NS) HD there is a 4-fold (significant) elevation in antibody titer to EBV-VAC, but no elevation to EBV-EA and EBNA; (2) in mixed cellularity (MC) HD a 10-fold (significant) elevation to both EBV-VCA and EA, but no elevation to EBNA is found compared to the control groups. These patterns in NS and MC HD are different from the pattern in nasopharyngeal carcinoma (NPC) which manifests elevations in antibody titers to EBV-VCA and EA as well as to EBNA. Antibody titers to HSV, VZV and CMV are not significantly elevated in either HD or NPC.
Similar articles
-
Herpesvirus group antibodies in children with Hodgkin's disease.Arch Virol. 1977;53(3):221-33. doi: 10.1007/BF01314666. Arch Virol. 1977. PMID: 193463
-
Antibodies against herpesviruses in patients with Hodgkin's disease.Arch Geschwulstforsch. 1983;53(5):417-22. Arch Geschwulstforsch. 1983. PMID: 6316868
-
Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.Int J Cancer. 1975 Aug 15;16(2):323-8. doi: 10.1002/ijc.2910160216. Int J Cancer. 1975. PMID: 168161
-
[Prevention and therapy of herpesvirus infections].Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Feb;180(2-3):107-20. Zentralbl Bakteriol Mikrobiol Hyg B. 1985. PMID: 2986378 Review. German.
-
The glycoproteins of the human herpesviruses.Comp Immunol Microbiol Infect Dis. 1991;14(2):81-95. doi: 10.1016/0147-9571(91)90123-u. Comp Immunol Microbiol Infect Dis. 1991. PMID: 1657514 Review.
Cited by
-
Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.Yale J Biol Med. 1987 Jul-Aug;60(4):321-32. Yale J Biol Med. 1987. PMID: 2821703 Free PMC article. Review.
-
Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.Clin Exp Immunol. 1978 Dec;34(3):338-46. Clin Exp Immunol. 1978. PMID: 217561 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous